Aimed Bio Inc. (KOSDAQ:0009K0)
South Korea
· Delayed Price · Currency is KRW
48,850
-2,050 (-4.03%)
At close: Apr 28, 2026
Aimed Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 3,152,719 | 3,695,395 | - | - | - |
| Enterprise Value | 2,983,059 | 3,612,198 | - | - | - |
| Last Close Price | 48750.00 | 57600.00 | - | - | - |
| PE Ratio | 627.71 | 735.76 | - | - | - |
| PS Ratio | 66.68 | 78.16 | - | - | - |
| PB Ratio | 16.37 | 19.19 | - | - | - |
| P/TBV Ratio | 16.51 | 19.35 | - | - | - |
| P/FCF Ratio | 180.09 | 211.09 | - | - | - |
| P/OCF Ratio | 176.52 | 206.91 | - | - | - |
| EV/Sales Ratio | 63.10 | 76.40 | - | - | - |
| EV/EBITDA Ratio | 134.67 | 163.07 | - | - | - |
| EV/EBIT Ratio | 143.63 | 173.93 | - | - | - |
| EV/FCF Ratio | 170.40 | 206.34 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.05 | 0.11 |
| Debt / EBITDA Ratio | 0.05 | 0.05 | 0.40 | - | - |
| Debt / FCF Ratio | 0.07 | 0.07 | - | - | - |
| Net Debt / Equity Ratio | -0.88 | -0.88 | -0.78 | -0.98 | -0.53 |
| Net Debt / EBITDA Ratio | -7.66 | -7.66 | -33.23 | 3.21 | 1.04 |
| Net Debt / FCF Ratio | -9.69 | -9.69 | 6.88 | 4.99 | 1.15 |
| Asset Turnover | 0.38 | 0.38 | 0.34 | 0.01 | - |
| Quick Ratio | 31.17 | 31.17 | 16.91 | 4.24 | 6.99 |
| Current Ratio | 31.43 | 31.43 | 17.02 | 4.25 | 7.13 |
| Return on Equity (ROE) | 4.23% | 4.23% | -10.62% | -66.75% | - |
| Return on Assets (ROA) | 10.55% | 10.55% | -0.73% | -24.04% | - |
| Return on Capital Employed (ROCE) | 10.70% | 10.70% | -0.90% | -35.60% | -55.90% |
| Earnings Yield | 0.16% | 0.14% | - | - | - |
| FCF Yield | 0.56% | 0.47% | - | - | - |
| Buyback Yield / Dilution | -39.98% | -39.98% | -4.02% | -2.16% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.